TuHURA Biosciences (HURA) Assets (2011 - 2026)

TuHURA Biosciences' Assets history runs 16 years deep, the most recent figure standing at $29.7 million for Q1 2026.

• On a quarterly basis, Assets rose 102.92% year-over-year to $29.7 million in Q1 2026; TTM through Mar 2026 was $29.7 million, a 102.92% increase from a year earlier, with the FY2025 full-year figure at $27.4 million, up 36.99% from the prior year.
• Assets grew to $29.7 million in Q1 2026 per HURA's latest filing, from $27.4 million in the prior quarter.
• Across five years, Assets topped out at $34.6 million in Q2 2025 and bottomed at $1.5 million in Q3 2023.
• The 5-year median for Assets is $12.8 million (2022), against an average of $14.0 million.
• Across the five-year window, Assets sank 88.82% in 2023 and jumped 520.7% in 2025, its largest moves.
• Year by year, Assets stood at $9.9 million in 2022, then plunged by 56.02% to $4.4 million in 2023, then soared by 357.76% to $20.0 million in 2024, then soared by 36.99% to $27.4 million in 2025, then advanced by 8.6% to $29.7 million in 2026.
• Per Business Quant, the three latest HURA Assets figures stand at $29.7 million (Q1 2026), $27.4 million (Q4 2025), and $25.7 million (Q3 2025).